ArticleInternational journal of hematology2019

Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan.

Masashi Taki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.